DJIA 18,030.21 6.04 0.03%
NASDAQ 4,773.47 0.00 0.00%
S&P 500 2,081.88 -0.29 -0.01%
market minute promo


company name or ticker
Company Photos
(Click to zoom)

Markets Mixed; Constellation Brands Posts Downbeat Profit

Markets Mixed; Constellation Brands Posts Downbeat Profit

Morning Market Movers

US Futures Turn Flat to Lower Despite Jobless Claims Drop; ECB Benchmark Interest Rates Unchanged

ARIAD Offers Updated Clinical Data on AP26113 in Patients with ALK+ Non-Small Cell Lung Cancer

Amgen Files Blinatumomab Marketing Application in U.S. - Analyst Blog

Amgen Files Blinatumomab Marketing Application in U.S. - Analyst Blog

Ariad Director Resignation May Mean CEO Berger One Step Closer to Exit

InsiderInsights.com Daily Round Up 9/11/14: LULU, ARIA, TITN, RSG

Why Ariad Pharmaceuticals, Inc. Stock Plunged 11% in 2014

Ariad's stock continues its double-digit percentage descent in 2014 following a rough 2013 campaign. Find out why shares continue to push lower and where Ariad's stock may head next.

Biotech Stock Mailbag: Achillion, Ariad Revisited, Endocyte

See More Articles...